Trace Neuroscience

On a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases

[Trace Neuroscience @TraceNeuro]

CEO @ercgrn will join @biospace alongside @CityTx_'s Andy Orth and Kivu Bioscience's Mo Trikha for a NextGen webinar focused on elevating your organization as biotech makes a come back. Register to join us here! https://t.co/d5dibVUGg8

[Trace Neuroscience @TraceNeuro]

To kick off #ALSAwarenessMonth, we had the privilege of welcoming Brian & Lori Andre to Trace. A truly extraordinary couple dedicated to making an impact in the fight against ALS through their mentorship and philanthropy, their words left us inspired and more motivated than ever.

[Trace Neuroscience @TraceNeuro]

We look forward to joining our #ALS network on the East Coast at the @TargetALS_fdn meeting this week! Preclinical Science lead Terry Fang will give an oral presentation on our latest research on the potential of UNC13A restoration as a treatment for people with ALS. More below.

[Trace Neuroscience @TraceNeuro]

We’re proud to share that CEO & co-founder @ercgrn has been named to @INVIVOnow's Rising Leaders! This list celebrates leaders shaping the future of health through bold thinking & meaningful impact, a vision Eric brings to advancing new approaches for ALS. https://t.co/iEPHCHfa1L

[Trace Neuroscience @TraceNeuro]

CEO @ercgrn & Scientific Founder Pietro Fratta will join @ALSCanada next weekend for ALS Disrupt! Join us for welcome remarks & the plenary lecture. We look forward to a weekend of collaborative discussion as we work to advance new therapies for #ALS. https://t.co/x2VdP4Z3oT

[Trace Neuroscience @TraceNeuro]

Trace CMO Irina Antonijevic looks forward to facilitating a roundtable on Wearables and Digital Biomarkers during this month's #CMOSummit360! Details below. Check out the full agenda on their website. https://t.co/PO660VCOwR

[Trace Neuroscience @TraceNeuro]

Trace Scientist Iris Bachmutsky is headed to San Diego for the 6th annual RNA Metabolism in Neurological Disease Conference! Her poster will be available for viewing during all poster sessions this Monday & Tuesday. Find more details in this year's agenda: https://t.co/Sac9Gd8nrA

[Trace Neuroscience @TraceNeuro]

The 2026 #MDAConference kicks off this weekend! We invite attendees to join preclinical science lead Terry Fang for viewing of our latest posters on our recent #ALS research during breaks on Monday, and at the poster & networking reception at 6PM. We look forward to connecting!

[Trace Neuroscience @TraceNeuro]

VP, Translational Sciences, Sanjay Chandriani, will speak on employing digital health technology assessments in #ALS trials at #ADDS2026 this afternoon! If you're in ATL for @actigraph's 2026 Digital Data Summit, join us in the Grand Ballroom @ 4:35PM. https://t.co/G3JLc7Vpd8

[Trace Neuroscience @TraceNeuro]

At Trace, 2/3 of our leadership team & over 1/2 of our broader team are women. Today, we celebrate them & all the incredible #WomenInScience and biotech who continue to advance drug development and move meaningful progress forward for people living with ALS and other diseases.♀️

[Trace Neuroscience @TraceNeuro]

We were excited to join @youralsnetwork at their Research Summit! We value opportunities to connect with the #ALS research community & advocates, and were grateful to share an industry update during the meeting. We look forward to more dialogue on advancing ALS research in 2026.

[Trace Neuroscience @TraceNeuro]

We're kicking off 2026 at #JPM26! Members of the Trace team @ercgrn, @NMordwinkin, Irina Antonijevic and Vanessa Yang will be in San Francisco and look forward to connecting and discussing our advancement of new approaches for #ALS.

[Trace Neuroscience @TraceNeuro]

We're thrilled to share we've been named to @BioSpace's NextGen Class of 2026! 1 in 400 people globally will be diagnosed with #ALS in their life. At Trace, we aim to change the fact that a majority will never receive effective treatment for their disease. https://t.co/MAk3VPoyR1

[Trace Neuroscience @TraceNeuro]

This year-end brings reflection, momentum, and a steady upward pace - all guiding us toward a promising new year at Trace.

We closed out 2025 with a cheery holiday celebration and look forward to all that #2026 has to offer. Happy New Year!

[Trace Neuroscience @TraceNeuro]

It was so special to welcome John Peffer to Trace. John was diagnosed with #ALS last year & is now a full-time advocate & fundraiser for ALS research. We admire his use of humor & positivity to raise awareness for ALS, primarily on his #TikTok: https://t.co/ivxoK5QeuO

[Trace Neuroscience @TraceNeuro]

It was energizing to connect with folks in the #ALS/#MND community this weekend at the annual #ALSMNDSymp! We're humbled & grateful to be part of this dedicated, innovative community. It takes a village to deliver new treatments for neurodegenerative diseases to patients in need.

[Trace Neuroscience @TraceNeuro]

Trace leaders are looking forward to sharing updates during the #ALSMNDSymp! Join us for an oral presentation on our lead development candidate, TRCN-1023, and three posters on our innovation in #ALS clinical trials throughout the weekend. Learn more below.

[Trace Neuroscience @TraceNeuro]

We loved spending time with David Buseck & Linda Levine, learning how they approach life with #ALS with positivity and purpose. Their adventurous spirit and resilience left us truly inspired.

Visit their websites:
https://t.co/Z2EeEj5Wmq
https://t.co/vBWVHh2o2w

[Trace Neuroscience @TraceNeuro]

1 in 400 people will be diagnosed with ALS in their lifetime. A year ago, we launched Trace Neuroscience to expand the promise of genetic medicine for all people with #ALS. We're grateful to continue driving our vision forward alongside the ALS community and our incredible team.

[Trace Neuroscience @TraceNeuro]

As @FierceBiotech put it, this year's #Fierce15 share one main common thread: "they're all challenging old ways of working." We were privileged to celebrate with our fellow 2025 honorees last night. We're proud to be recognized as leaders in next-gen biotech innovation.